Walleye Capital LLC Nkarta, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.59 - $15.71 $693,825 - $1.95 Million	124,119 New	124,119 $1.34 Million
Q2 2022 Aug 08, 2022	SELL	$7.77 - $19.44 $358,064 - $895,853	-46,083 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.66 - $14.99 $138,308 - $239,405	15,971 Added 53.04%	46,083 $524,000
Q4 2021 Mar 03, 2022	BUY	$12.79 - $26.88 $385,132 - $809,410	30,112 New	30,112 $462,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.